BioCentury
ARTICLE | Finance

Quake-starting Karius

How ex-Moleculo team, investor plan to deploy a $50M series A for Karius

August 11, 2017 7:26 PM UTC

The former management team and seed investor behind sequencing company Moleculo Inc. have reunited at Karius Inc., and plan to use a new untranched $50 million series A round to launch Karius' infectious disease diagnostic nationwide and build a company that will quickly become cash positive.

Karius' co-founders include CEO Mickey Kertesz, CSO Tim Blauwkamp and SAB Chair Stephen Quake. ...

BCIQ Company Profiles

Karius Inc.